Menu
Recruiting NCT07067983

Clinical Evaluation of GRAPE Model for Gastric Cancer Screening

— Observational Gastric Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Results following systematic screening.
Who it may be relevant to
Registry conditions: Gastric Cancer. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

A Prospective Study Evaluating the Performance of the GRAPE Model in Gastric Cancer Screening and Its Detection Rates Across Different Disease Stages

Interventions

  • Diagnostic test Results following systematic screening
    The GRAPE model's output (positive or negative) determines whether patients require follow-up gastroscopy

Primary outcome measures

  • GRAPE systematic screening results [Time frame: first visited at baseline]

Eligibility criteria

Inclusion criteria

  • Aged between 18 and 80 years
  • Individuals undergoing thoracoabdominal CT examination
  • Voluntarily participated in the study and provided written informed consent

Exclusion criteria

  • Patients with confirmed diagnosis of gastric cancer
  • Individuals with severe intellectual disabilities or communication disorders

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-only

Study locations

China · 1 center
  • Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital — Hangzhou

Identifiers

NCT: NCT07067983 · IIT-2025-160

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗